We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIMB icon
4001
TIM SA
TIMB
$8.27B
$13K ﹤0.01%
+1,184
New +$16.2K
TLT icon
4002
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
$13K ﹤0.01%
+80
New +$13.3K
BSIN
4003
Big Sky Industrial
BSIN
$73.5M
$13K ﹤0.01%
2,622
+2,459
+1,509% +$13K
VHI icon
4004
Valhi
VHI
$457M
$13K ﹤0.01%
963
-6,473
-87% -$77.6K
VTGN icon
4005
VistaGen Therapeutics
VTGN
$11.6M
$13K ﹤0.01%
631
+225
+55% +$4.66K
VTSI icon
4006
VirTra
VTSI
$36.2M
$13K ﹤0.01%
3,330
+3,183
+2,165% +$11.8K
XELB icon
4007
Xcel Brands
XELB
$6.18M
$13K ﹤0.01%
1,650
+1,440
+686% +$11.7K
USAP
4008
DELISTED
Universal Stainless & Alloy
USAP
$13K ﹤0.01%
2,440
+2,328
+2,079% +$16.6K
AGR
4009
DELISTED
Avangrid, Inc.
AGR
$13K ﹤0.01%
264
-8,754
-97% -$421K
FREE
4010
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$13K ﹤0.01%
+1,568
New +$12.3K
TGA
4011
DELISTED
Transglobe Energy Corp
TGA
$13K ﹤0.01%
+34,500
New +$18.7K
NEOS
4012
DELISTED
Neos Therapeutics, Inc
NEOS
$13K ﹤0.01%
24,969
+2,926
+13% +$1.99K
CBPO
4013
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$13K ﹤0.01%
115
-792
-87% -$85K
AEYE icon
4014
AudioEye
AEYE
$101M
$12K ﹤0.01%
803
+514
+178% +$7.75K
BMA icon
4015
Banco Macro
BMA
$4.99B
$12K ﹤0.01%
+845
New +$16.4K
BSTZ icon
4016
BlackRock Science and Technology Term Trust
BSTZ
$2.18B
$12K ﹤0.01%
+461
New +$11.5K
CLOV icon
4017
Clover Health Investments
CLOV
$2.43B
$12K ﹤0.01%
+1,000
New +$11.1K
DALN
4018
DELISTED
DallasNews
DALN
$12K ﹤0.01%
+2,136
New +$13.4K
DARE icon
4019
Dare Bioscience
DARE
$21.6M
$12K ﹤0.01%
1,019
-99
-9% -$1.32K
DCTH icon
4020
Delcath Systems
DCTH
$586M
$12K ﹤0.01%
1,026
+147
+17% +$1.64K
FTAI icon
4021
FTAI Aviation
FTAI
$22.3B
$12K ﹤0.01%
848
-434
-34% -$5.76K
FTHM icon
4022
Fathom Holdings
FTHM
$24.7M
$12K ﹤0.01%
+731
New +$10.9K
IBN icon
4023
ICICI Bank
IBN
$106B
$12K ﹤0.01%
1,183
-16,944
-93% -$169K
IGIB icon
4024
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$12K ﹤0.01%
194
-167
-46% -$10.2K
KMDA icon
4025
Kamada
KMDA
$433M
$12K ﹤0.01%
+1,462
New +$13.3K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.